Skip to main content
Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News FAQ
On This Report

Cardiovascular Anastomosis Devices Market Size & Growth Forecast 2027–2036, By Segments (Product Type, End-Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 15070| Published Date: Aug-2026| Format: PDF, Excel
Market Outlook

Market Size and Growth Outlook

Cardiovascular Anastomosis Devices Market size was estimated at USD 2.02 billion in 2026 and is projected to grow at a 6.18% CAGR from 2027 to 2036, reaching USD 3.68 billion by 2036. The industry revenue for 2027 is calculated at USD 2.13 billion.

Base Year Value (2026)
USD 2.02 billion
CAGR (2027-2036)
6.18%
Forecast Year Value (2036)
USD 3.68 billion
Historical Data Period
2022-2026
Largest Region
North America
Forecast Period
2027-2036

Get more details on this report

Request Free Sample Report
Snapshot

Cardiovascular Anastomosis Devices Market Intelligence Snapshot

Regional Market Dynamics

  • North America accounted for 45.58% of the market in 2026, supported by high cardiac surgery volumes, advanced hospital infrastructure, and widespread adoption of specialized surgical devices.
  • Asia Pacific is projected to grow at a 7.46% CAGR as surgical access expands, cardiac treatment capacity increases, and healthcare providers adopt advanced cardiovascular surgical technologies.

Segment Momentum

  • Manual devices hold a 60.92% share due to strong surgeon familiarity, established workflows, and broad applicability across procedures where direct control remains essential in vessel connection techniques.
  • Automatic devices are growing fastest as hospitals seek faster, more standardized vessel joining methods that improve procedural efficiency and consistency in complex cardiovascular surgeries.

Market Expansion Drivers

  • Increasing cardiovascular disease prevalence driving higher surgical intervention demand globally.
  • Rising adoption of minimally invasive and off-pump cardiac procedures improving device utilization.
  • Medical technology innovation improving graft patency and surgical precision in cardiac procedures.

Leading Market Participants

  • Key players in the cardiovascular anastomosis devices market include Abbott Laboratories (United States), Medtronic plc (Ireland), B. Braun Melsungen AG (Germany), Getinge AB (Sweden), Terumo Corporation (Japan), Edwards Lifesciences Corporation (United States), Johnson & Johnson (Ethicon Inc.) (United States), LivaNova PLC (United Kingdom), Peters Surgical (France), MicroPort Scientific Corporation (China).

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 2.02 billion
  • 2027 Estimated Market Size: USD 2.13 billion.
  • Projected Market Size: USD 3.68 billion by 2036
  • Growth Forecast: 6.18% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Manual (Product Type) | Hospitals (End-Use)
  • Emerging Opportunity Segment: Automatic (Product Type) | Specialty Clinics (End-Use)
Market Dynamics

Market Growth Drivers and Industry Trends

Increasing cardiovascular disease prevalence driving higher surgical intervention demand globally

The growing burden of cardiovascular diseases is increasing the need for surgical procedures that restore or maintain blood flow in affected vessels, supporting cardiovascular anastomosis devices market growth. As more patients require coronary artery bypass grafting and other vascular reconstruction procedures, surgeons increasingly depend on reliable anastomosis solutions to establish secure connections between blood vessels and grafts. The rising incidence of conditions such as coronary artery disease, peripheral vascular complications, and other cardiovascular disorders is also expanding the pool of patients requiring operative intervention. Greater emphasis on timely treatment and improved surgical outcomes is encouraging healthcare providers to adopt devices that can facilitate consistent vessel joining, reduce procedural complexity, and support efficient tissue handling during cardiac operations.

Rising adoption of minimally invasive and off-pump cardiac procedures improving device utilization

The shift toward less invasive cardiac interventions is creating additional opportunities for cardiovascular anastomosis devices market expansion as healthcare providers seek techniques that can reduce surgical trauma and recovery requirements. Minimally invasive and off-pump procedures require precise vascular connections while limiting manipulation of the heart and surrounding tissues, increasing the importance of specialized anastomosis technologies. Devices designed to support controlled and efficient vessel joining can help surgeons manage restricted operative access and maintain procedural accuracy without relying entirely on conventional open-heart approaches. Growing clinical interest in reducing blood loss, shortening hospitalization, and improving postoperative recovery is encouraging wider use of anastomosis solutions compatible with evolving cardiac surgical techniques.

Medical technology innovation improving graft patency and surgical precision in cardiac procedures

Advances in medical device engineering are strengthening the cardiovascular anastomosis devices market by addressing the need for more precise vessel connections and durable graft performance. Innovations in device design, deployment mechanisms, and surgical guidance are helping clinicians achieve greater consistency when connecting grafts to blood vessels, while improvements in material and mechanical characteristics can support secure anastomotic sites. Technologies that simplify positioning, reduce the potential for technical variability, and improve visualization during procedures are particularly relevant to complex cardiac surgeries. Continued development of solutions focused on maintaining graft patency and minimizing complications is encouraging surgeons and healthcare institutions to incorporate newer anastomosis technologies into cardiac procedure workflows.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Increasing cardiovascular disease prevalence driving higher surgical intervention demand globally 2.20% High North America, Europe High Near Term
Rising adoption of minimally invasive and off-pump cardiac procedures improving device utilization 2.00% High North America, Europe Medium Mid Term
Medical technology innovation improving graft patency and surgical precision in cardiac procedures 1.80% High North America, Asia Pacific Medium Mid Term
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Regional Forecast

Regional Demand Dynamics

Cardiovascular Anastomosis Devices Market
Largest Region
North America
45.58% Market Share in 2026

North America (Largest Region)

North America held the largest share of the cardiovascular anastomosis devices market at 45.58% in 2026, supported by advanced cardiovascular care infrastructure, established surgical capabilities, and strong adoption of sophisticated medical technologies. The region's healthcare systems emphasize minimally invasive and precision-oriented procedures, creating demand for devices that can support efficient vascular connections during complex cardiovascular interventions. Continued investment in surgical innovation and specialized clinical infrastructure further strengthens the regional market position.

Asia Pacific (Fastest-Growing Region)

Asia Pacific is the fastest-growing region, driven by expanding healthcare infrastructure, increasing access to cardiovascular procedures, and rising demand for advanced surgical technologies. Improvements in hospital capabilities and growing investment in specialized cardiovascular care are supporting greater adoption of anastomosis devices. Increasing awareness of advanced treatment options and the modernization of healthcare facilities are also creating favorable conditions for broader use of these devices across the region.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
Country Insights

Key Country Insights

Germany 🇩🇪

Precision Cardiac Procedure Focus

Germany's market is supported by specialized cardiac centers seeking technologies that improve surgical precision and patient outcomes. Manufacturers in Germany are focusing on device reliability and compatibility with advanced cardiovascular procedures performed in highly specialized healthcare settings.

France 🇫🇷

Specialized Cardiac Care Integration

France's cardiovascular anastomosis devices market is supported by established cardiac treatment networks and growing interest in procedural innovation. Healthcare institutions in France are prioritizing technologies that enhance surgical consistency and support complex cardiovascular interventions.

Italy 🇮🇹

Cardiovascular Procedure Modernization

Italy continues to adopt cardiovascular anastomosis devices as cardiac centers seek tools that improve procedural outcomes and streamline surgery. The market in Italy is increasingly focused on technologies that support precision in vascular reconstruction and facilitate advanced cardiac treatment approaches.

Japan 🇯🇵

Efficiency-Oriented Surgical Solutions

In Japan, cardiovascular anastomosis devices are gaining attention as healthcare providers pursue technologies that shorten procedure times and support an aging patient population. The market in Japan is emphasizing devices that facilitate standardized surgical performance and reduce procedural complexity.

South Korea 🇰🇷

Minimally Invasive Cardiac Expansion

South Korea is increasingly integrating cardiovascular anastomosis devices into advanced cardiac surgery programs and minimally invasive procedures. Hospitals in South Korea are investing in technologies that improve surgical efficiency and align with broader efforts to modernize cardiovascular care capabilities.

United States 🇺🇸

Advanced Surgical Technology Adoption

The U.S. cardiovascular anastomosis devices market is driven by demand for technologies that improve procedural efficiency and support minimally invasive cardiac interventions. Healthcare providers in the U.S. are increasingly adopting devices that reduce operative complexity and enhance consistency in vascular connections.

Segment Analysis

Segment Leadership and Growth Trends

Cardiovascular Anastomosis Devices Market Share (%), by Product Type, 2026

Manual
Automatic

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Product Type Segment Analysis: Manual (Largest Segment) vs Automatic (Fastest-Growing Segment)

Manual devices held the largest share of the cardiovascular anastomosis devices market in 2026, accounting for 60.92% of the market. Their established use in cardiovascular procedures is supported by familiarity among surgeons and the ability to provide direct control during delicate vessel-joining procedures. Manual techniques can also offer flexibility in adapting to variations in vessel anatomy and surgical conditions. Continued demand for cardiovascular interventions and the established role of surgeon-controlled approaches in complex procedures are sustaining the segment's leading position.

Automatic devices are gaining adoption as healthcare providers increasingly seek technologies that can improve procedural consistency, simplify complex surgical steps, and potentially reduce technical demands. Automation can support more standardized anastomosis procedures while contributing to workflow efficiency and precision. Growing interest in minimally invasive and technologically advanced cardiovascular interventions is encouraging investment in automated surgical technologies, creating stronger growth opportunities for this segment.

End-Use Segment Analysis: Hospitals (Largest Segment) vs Specialty Clinics (Fastest-Growing Segment)

Hospitals represented the largest end-use segment of the cardiovascular anastomosis devices market in 2026, with a 61.11% share. Hospitals remain central to cardiovascular care because they provide advanced surgical infrastructure, specialized operating facilities, intensive monitoring, and multidisciplinary clinical expertise. The concentration of complex cardiovascular procedures within hospital settings supports sustained demand for anastomosis devices. Continued investment in surgical capabilities and the need to manage patients requiring advanced cardiovascular interventions further reinforce hospital-based adoption.

Specialty clinics are experiencing faster growth as cardiovascular care increasingly incorporates specialized treatment settings designed to improve accessibility and procedural efficiency. These facilities can offer focused expertise and streamlined care pathways for selected cardiovascular interventions. Expansion of specialized outpatient and ambulatory care models, together with efforts to reduce treatment burdens and improve patient convenience, is creating greater opportunities for anastomosis device adoption in specialty clinics.

Segment Sub-Segment Largest Segment Fastest Growing
Product Type Automatic, Manual Manual Automatic
End-Use Hospitals, Ambulatory Surgical Centers, Specialty Clinics Hospitals Specialty Clinics
Read our Research Approach →
Competitive Landscape

Competitive Landscape and Market Positioning

Top players in the cardiovascular anastomosis devices market:

1. Abbott Laboratories (United States)

2. Medtronic plc (Ireland)

3. B. Braun Melsungen AG (Germany)

4. Getinge AB (Sweden)

5. Terumo Corporation (Japan)

6. Edwards Lifesciences Corporation (United States)

7. Johnson & Johnson (Ethicon Inc.) (United States)

8. LivaNova PLC (United Kingdom)

9. Peters Surgical (France)

10. MicroPort Scientific Corporation (China)

Continuous innovation in cardiovascular surgery is advancing the cardiovascular anastomosis devices market, with research focused on precision surgical devices, minimally invasive procedures, and improved vessel connection technologies. These developments are enhancing procedural efficiency and patient outcomes.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
Abbott Laboratories (United States)
Medtronic plc (Ireland)
B. Braun Melsungen AG (Germany)
Getinge AB (Sweden)
Terumo Corporation (Japan)
Edwards Lifesciences Corporation (United States)
Johnson & Johnson (Ethicon Inc.) (United States)
LivaNova PLC (United Kingdom)
Peters Surgical (France)
MicroPort Scientific Corporation (China).
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
GT Metabolic Solutions, Inc. Sep-24 GT Metabolic Solutions received FDA De Novo marketing authorization for its MagDI System designed for side-to-side duodeno-ileal anastomosis in bariatric and metabolic surgery. The approval enables commercialization of a novel anastomosis technology intended to improve gastrointestinal surgical outcomes and expand minimally invasive procedural capabilities in advanced cardiovascular and metabolic surgical applications.
Exero Medical May-24 Exero Medical initiated an international pivotal multi-center clinical study for its xBar system, an FDA breakthrough-designated device using post-surgical tissue monitoring technology. The study evaluates its ability to provide real-time healing data after gastrointestinal surgery, supporting improved postoperative management and earlier detection of complications that may be relevant to anastomosis-related surgical recovery pathways.
Intuitive Surgical Inc. Jun-21 Intuitive Surgical launched the SureForm surgical stapler equipped with SmartFire technology, integrating software-driven control to improve staple formation and tissue compression consistency. The product enhances robotic-assisted surgical precision and supports improved outcomes in tissue anastomosis procedures through automated adjustment of stapling force during operations.
Johnson & Johnson Mar-21 Johnson & Johnson introduced the ECHELON+ powered surgical stapler designed to improve surgical precision through more uniform tissue compression and optimized staple formation. The device aims to reduce surgical complications and enhance consistency in tissue anastomosis procedures, strengthening the company’s surgical device portfolio within minimally invasive cardiovascular and general surgery applications.
Medtronic plc Mar-19 Medtronic plc acquired EPIX Therapeutics, a catheter-based cardiac ablation system developer, expanding its cardiac arrhythmia treatment portfolio. The acquisition strengthens Medtronic’s cardiovascular intervention capabilities by integrating advanced ablation technologies into its existing suite of cardiac surgical and electrophysiology tools, enhancing its position in minimally invasive cardiovascular treatment solutions.
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Cardiovascular Anastomosis Devices Market — Custom Segments

Segment Sub-Segment
Procedure Type Coronary Artery Bypass Grafting, Peripheral Vascular Bypass, Aortic and Other Cardiovascular Procedures
Vessel Type Coronary Arteries, Peripheral Arteries, Aorta and Major Vessels, Other Cardiovascular Vessels
Clinical Indication Coronary Artery Disease, Peripheral Arterial Disease, Aortic Disease, Congenital and Other Cardiovascular Conditions

Cardiovascular Anastomosis Devices Market — Custom TOC

Custom Chapter Custom Details
Hospital Procurement and Purchasing Strategy
  • Hospital Procurement Models and Decision-Making Structures
  • Clinical, Economic, and Operational Purchasing Criteria
  • Surgeon and Operating Room Stakeholder Priorities
  • Tendering, Contracting, and Vendor Qualification Requirements
  • Procurement Barriers and Market Access Opportunities
Clinical Adoption and Surgeon Preferences
  • Adoption Pathways Across Cardiac Surgery Settings
  • Surgeon Preferences and Procedure-Specific Requirements
  • Clinical Evidence and Training Considerations
  • Barriers to Device Adoption and Practice Change
  • Adoption Enablers and Priority Clinical Centers
Reimbursement and Market Access Strategy
  • Reimbursement Landscape Across Key Healthcare Systems
  • Procedure and Device Coverage Considerations
  • Hospital Economics and Value Demonstration Requirements
  • Payer and Provider Access Barriers
  • Market Access Priorities and Evidence Needs

Need a different cut of the data?

Request Custom Research
Frequently Asked Questions

How big is the cardiovascular anastomosis devices market?

The market size of the cardiovascular anastomosis devices is estimated at USD 2.13 billion in 2027.

How will the cardiovascular anastomosis devices industry grow in terms of size and CAGR by 2036?

Cardiovascular Anastomosis Devices Market size was estimated at USD 2.02 billion in 2026 and is projected to grow at a 6.18% CAGR from 2027 to 2036, reaching USD 3.68 billion by 2036.

How is the shift toward minimally invasive cardiac procedures affecting adoption of cardiovascular anastomosis devices?

Minimally invasive and off-pump procedures increase demand for device-assisted vessel joining that improves control, speed, and procedural consistency. Healthcare providers increasingly favor solutions that support efficient workflows while addressing the technical challenges of limited surgical access.

Why is medical technology innovation strategically important in the cardiovascular anastomosis devices market?

Advances in device design and deployment improve surgical precision and graft connection quality, increasing confidence in device-assisted procedures. Manufacturers that deliver more reliable handling and consistent performance strengthen their competitive position in clinical procurement decisions.

Why do manual devices dominate the cardiovascular anastomosis devices market?

Manual devices hold a 60.92% share due to strong surgeon familiarity, established workflows, and broad applicability across procedures where direct control remains essential in vessel connection techniques.

What is driving the growth of automatic devices in cardiovascular anastomosis procedures?

Automatic devices are growing fastest as hospitals seek faster, more standardized vessel joining methods that improve procedural efficiency and consistency in complex cardiovascular surgeries.

Why is North America the leading region in the cardiovascular anastomosis devices market?

North America accounted for 45.58% of the market in 2026, supported by high cardiac surgery volumes, advanced hospital infrastructure, and widespread adoption of specialized surgical devices.

What is driving growth in the cardiovascular anastomosis devices market across Asia Pacific?

Asia Pacific is projected to grow at a 7.46% CAGR as surgical access expands, cardiac treatment capacity increases, and healthcare providers adopt advanced cardiovascular surgical technologies.

Who are the major participants shaping the cardiovascular anastomosis devices landscape?

Key players in the cardiovascular anastomosis devices market include Abbott Laboratories (United States), Medtronic plc (Ireland), B. Braun Melsungen AG (Germany), Getinge AB (Sweden), Terumo Corporation (Japan), Edwards Lifesciences Corporation (United States), Johnson & Johnson (Ethicon Inc.) (United States), LivaNova PLC (United Kingdom), Peters Surgical (France), MicroPort Scientific Corporation (China).
Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →